公开(公告)号：US20160007192A1

公开(公告)日：2016-01-07

申请号：US14708309

申请日：2015-05-11

Applicant: I-SHOU UNIVERSITY

Inventor： Yu-Jung Huang ,  Hsuan-Hsun Wu

IPC: H04W12/04

CPC classification number: H04W12/04 ,  G06F19/00 ,  H04L9/0863 ,  H04L9/0869 ,  H04L9/0891 ,  H04L67/12 ,  H04L2209/805 ,  H04W4/70 ,  H04W12/02 ,  H04W12/06 ,  H04W84/18

Abstract: The invention is directed to a wireless sensor network system. The wireless sensor network system is adapted for a medication information security environment, and the wireless sensor network system comprising a first sensor node, a second sensor node and a central node. The first sensor node sends a request for registration and a user identification. The central node generates and stores a first set of random number and a second set of random number when receiving the request for registration and the user identification. The central node sends the first set of random number and the second set of random number to the first sensor node and the second sensor node respectively.

Abstract translation: 本发明涉及无线传感器网络系统。 所述无线传感器网络系统适用于药物信息安全环境，所述无线传感器网络系统包括第一传感器节点，第二传感器节点和中心节点。 第一传感器节点发送注册请求和用户标识。 当接收到注册请求和用户标识时，中心节点生成并存储第一组随机数和第二组随机数。 中央节点分别将第一组随机数和第二组随机数发送给第一传感器节点和第二传感器节点。

公开(公告)号：US09216190B2

公开(公告)日：2015-12-22

申请号：US14057935

申请日：2013-10-18

Applicant: I-SHOU UNIVERSITY

Inventor： Ping-Heng Tan

IPC: A61K31/713 ,  A61K9/00

CPC classification number: A61K31/713 ,  A61K9/0019

Abstract: An analgesic medication includes an oligonucleotide being a double strand RNA comprising 18 to 70 base pairs, and a pharmaceutical acceptable vehicle for delivering the said oligonucleotide into cells, wherein a dosage of the oligonucleotide in the analgesic is 50 μg to 200 μg/kg per time, and the pharmaceutical acceptable vehicle is selected from a group of polyethyleneimine, lipofectamine and iFect.

Abstract translation: 镇痛药包括含有18〜70个碱基对的双链RNA的寡核苷酸，以及用于将所述寡核苷酸递送到细胞中的药物可接受载体，其中所述镇痛剂中的寡核苷酸的剂量为每次50μg至200μg/ kg ，并且药物可接受的载体选自聚乙烯亚胺，脂质体和iFect组。

公开(公告)号：US09138726B2

公开(公告)日：2015-09-22

申请号：US13961470

申请日：2013-08-07

Applicant: I-SHOU UNIVERSITY

Inventor： Shih-Han Wang ,  Ming-Tsai Liang ,  Yuh-Wern Wu

IPC: B01J23/72 ,  C01B21/02

CPC classification number: B01J23/72 ,  C01B3/047 ,  C01B21/02 ,  Y02E60/364

Abstract: A copper-based catalyst which is suitable for converting ammonia of high concentration and with better selectivity, thereby solving a problem of pollution and toxicity due to nitrogen oxides by a conventional catalyst reacting under high temperature is disclosed. The copper-based catalyst comprises: a porous oxide support and a low valent copper compound mixing with the porous oxide support by an acid hydrothermal method; wherein the low valent copper compound with is Cu and Cu2O.

Abstract translation: 公开了一种适用于高浓度氨和较好选择性氨转化的铜基催化剂，从而通过常规催化剂在高温下反应而解决了由氮氧化物引起的污染和毒性问题。 铜基催化剂包括：通过酸性水热法与多孔氧化物载体混合的多孔氧化物载体和低价铜化合物; 其中所述低价铜化合物是Cu和Cu 2 O。

公开(公告)号：US20150232956A1

公开(公告)日：2015-08-20

申请号：US14262266

申请日：2014-04-25

Applicant: I-SHOU UNIVERSITY

Inventor： YUN-JU CHEN ,  WEI-CHIEN HUANG ,  JHEN-YU CHEN ,  PEI-HSUAN CHIEN ,  WEN-SHU CHEN

IPC: C12Q1/70 ,  C12Q1/68

CPC classification number: C12Q1/706 ,  C12Q1/6886 ,  C12Q2600/106 ,  C12Q2600/158

Abstract: The invention discloses a method for evaluating therapeutic effects of lapatinib on liver cancer comprising: obtaining a liver cancer biopsy from a patient; determining level of a biomarker in the liver cancer biopsy obtained from the patient ex vivo; comparing the determined level of the biomarker in the liver cancer biopsy obtained from the patient to a reference level of the biomarker; and predicting therapeutic effect of lapatinib on liver cancer according to the comparison between the determined level and the reference level of the biomarker; wherein the reference level of the biomarker is level of the biomarker in a liver biopsy obtained from a normal, non-cancerous subject; wherein the biomarker is HBx or ErbB3.

Abstract translation: 本发明公开了一种评估拉帕替尼对肝癌治疗效果的方法，包括：从患者获得肝癌活检; 确定从患者体内获得的肝癌活检中生物标志物的水平; 将从患者获得的肝癌活检中的生物标志物的确定水平与生物标志物的参考水平进行比较; 并根据确定的水平与生物标志物的参考水平之间的比较预测拉帕替尼对肝癌的治疗效果; 其中所述生物标志物的参考水平是从正常非癌症受试者获得的肝活组织检查中的生物标志物的水平; 其中所述生物标志物是HBx或ErbB3。

公开(公告)号：US20150010092A1

公开(公告)日：2015-01-08

申请号：US14053612

申请日：2013-10-15

Applicant: I-SHOU UNIVERSITY

Inventor： Chun-Wei Huang ,  Yu-Jung Huang ,  Ming-Kun Chen

IPC: H04B5/00

CPC classification number: H04B5/0075 ,  H04B5/0031

Abstract: A signal transmission system and a signal transmission circuit are provided. The system includes a first chip and a second chip. A rising pulse signal (RPS) and a falling pulse signal (FPS) are generated by a transmission module on the first chip in response to a waveform of an input signal. The RPS corresponds to rising edges of the input signal, the FPS corresponds to falling edges of the input signal, and the RPS and the FPS are transmitted by a first transmission unit and a second transmission unit both located on a surface of the first

Abstract translation: 提供信号传输系统和信号传输电路。 该系统包括第一芯片和第二芯片。 响应于输入信号的波形，由第一芯片上的传输模块产生上升脉冲信号（RPS）和下降脉冲信号（FPS）。 RPS对应于输入信号的上升沿，FPS对应于输入信号的下降沿，并且RPS和FPS由第一传输单元和第二传输单元传送，第一传输单元和第二传输单元都位于第一

公开(公告)号：US20140278161A1

公开(公告)日：2014-09-18

申请号：US13842637

申请日：2013-03-15

Applicant: I-SHOU UNIVERSITY

Inventor： Chao-Shun CHEN ,  Shang-Wen LUAN ,  Jen-Hao TENG ,  Kuo-Chun TING ,  Wei-Hao HUANG

IPC: G01R31/08

CPC classification number: G01R31/088 ,  H02H1/0061 ,  H02H7/261

Abstract: A method for determining a signal transmission mode of a plurality of fault indicators includes a data retrieval step, a mode setting step, a number setting step, an analysis step, a first determination step, a calculation step, a second determination step and a mode number increasing step. Based on the above step, the method is able to determine a preferred number of times the fault signals are required to be transmitted between the plurality of fault indicators when a predetermined transmission success rate is met, reducing the energy consumption and prolonging the service life of the indicators.

Abstract translation: 用于确定多个故障指示器的信号传输模式的方法包括数据检索步骤，模式设置步骤，数字设置步骤，分析步骤，第一确定步骤，计算步骤，第二确定步骤和模式 数增加步。 基于上述步骤，当满足预定的传输成功率时，该方法能够确定在多个故障指示器之间需要发送的故障信号的优选次数，从而降低能量消耗并延长其使用寿命 指标。

公开(公告)号：US20140255385A1

公开(公告)日：2014-09-11

申请号：US13785517

申请日：2013-03-05

Applicant: I SHOU UNIVERSITY

Inventor： Chih-Hui YANG ,  Keng-Shiang HUANG ,  Ya-Hui HSIEH

IPC: A61K36/062

CPC classification number: A61K36/068

Abstract: Disclosed herein is that an active ingredient obtained from cultivation of Cordyceps militaris can be used in the treatment of glioblastoma.

Abstract translation: 本文公开的是将从虫草虫草中培养得到的活性成分可用于治疗胶质母细胞瘤。

公开(公告)号：US20140219450A1

公开(公告)日：2014-08-07

申请号：US13761144

申请日：2013-02-06

Applicant: I-SHOU UNIVERSITY

Inventor： Yu-Jung Huang ,  Hsuan-Hsun Wu

IPC: H04W12/02

CPC classification number: H04W12/04 ,  G06F19/00 ,  H04L9/0863 ,  H04L9/0869 ,  H04L9/0891 ,  H04L67/12 ,  H04L2209/805 ,  H04W4/70 ,  H04W12/02 ,  H04W12/06 ,  H04W84/18

Abstract: The invention is directed to a wireless sensor network system. The wireless sensor network system is adapted for a medication information security environment, and the wireless sensor network system comprising a first sensor node, a second sensor node and a central node. The first sensor node sends a request for registration and a user identification. The central node generates and stores a first set of random number and a second set of random number when receiving the request for registration and the user identification. The central node sends the first set of random number and the second set of random number to the first sensor node and the second sensor node respectively.

Abstract translation: 本发明涉及无线传感器网络系统。 所述无线传感器网络系统适用于药物信息安全环境，所述无线传感器网络系统包括第一传感器节点，第二传感器节点和中心节点。 第一传感器节点发送注册请求和用户标识。 当接收到注册请求和用户标识时，中心节点生成并存储第一组随机数和第二组随机数。 中央节点分别将第一组随机数和第二组随机数发送给第一传感器节点和第二传感器节点。

公开(公告)号：US20140113325A1

公开(公告)日：2014-04-24

申请号：US13802626

申请日：2013-03-13

Applicant: I-SHOU UNIVERSITY

Inventor： Jau-Yann Wu ,  Li-Feng Liu ,  Kuan-Ju Pan ,  Hao-Yu Tseng ,  Jian-Ching Wu

IPC: C12Q1/04 ,  G01N33/94 ,  C12Q1/02 ,  G01N33/50

CPC classification number: C12Q1/04 ,  C12Q1/02 ,  C12Q1/025 ,  G01N33/50 ,  G01N33/5044 ,  G01N33/5091 ,  G01N33/569 ,  G01N33/574 ,  G01N33/582 ,  G01N33/94 ,  G01N2400/00 ,  G01N2500/00

Abstract: The disclosure provides a use of a fluorescent saccharide-based derivative in cell detection. The fluorescent saccharide-based derivative is obtained from a reactive material through an imine formation reaction, and the reactive material is selected from a composition (A) or a composition (B). The composition (A) includes a reducing sugar compound and an amino group-containing compound having at least one primary amino group. The composition (B) includes an amino sugar compound and a carbonyl group-containing compound, and the amino sugar compound contains at least one primary amino group.

Abstract translation: 本公开提供了基于荧光糖的衍生物在细胞检测中的用途。 荧光糖基衍生物通过亚胺形成反应由反应性材料获得，反应性材料选自组合物（A）或组合物（B）。 组合物（A）包括还原糖化合物和具有至少一个伯氨基的含氨基化合物。 组合物（B）包括氨基糖化合物和含羰基化合物，氨基糖化合物含有至少一个伯氨基。

公开(公告)号：US11817782B2

公开(公告)日：2023-11-14

申请号：US17569546

申请日：2022-01-06

Applicant: I SHOU UNIVERSITY

Inventor： Chien-Hsuan Chang ,  Yi-Fan Chen

IPC: H02M3/158 ,  H02M7/48 ,  H02M1/00

CPC classification number: H02M3/158 ,  H02M1/007 ,  H02M1/0054 ,  H02M3/1582 ,  H02M7/4807

Abstract: An inverter device includes a converter circuit and a filter. The converter circuit converts a DC input voltage into an AC intermediate voltage based on six control signals, and includes first and second converters. Each of the first and second converters includes three switches, two diodes and a coupled inductor circuit. The switches of the first converter operate respectively based on three of the control signals. The switches of the second converter operate respectively based on the other three of the control signals. The filter filters the AC intermediate voltage to generate an AC output voltage.